Cargando…

New Insights into Bitopic Orthosteric/Allosteric Ligands of Cannabinoid Receptor Type 2

Very recently, we have developed a new generation of ligands targeting the cannabinoid receptor type 2 (CB2R), namely JR compounds, which combine the pharmacophoric portion of the CB2R positive allosteric modulator (PAM), EC21a, with that of the CB2R selective orthosteric agonist LV62, both synthesi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferrisi, Rebecca, Polini, Beatrice, Ricardi, Caterina, Gado, Francesca, Mohamed, Kawthar A., Baron, Giovanna, Faiella, Salvatore, Poli, Giulio, Rapposelli, Simona, Saccomanni, Giuseppe, Aldini, Giancarlo, Chiellini, Grazia, Laprairie, Robert B., Manera, Clementina, Ortore, Gabriella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917213/ https://www.ncbi.nlm.nih.gov/pubmed/36768458 http://dx.doi.org/10.3390/ijms24032135

Ejemplares similares

Design, synthesis and biological evaluation of novel orthosteric-allosteric ligands of the cannabinoid receptor type 2 (CB(2)R)
por: Ferrisi, Rebecca, et al.
Publicado: (2022)

Design, Synthesis, and Biological Activity of New CB2 Receptor Ligands: from Orthosteric and Allosteric Modulators to Dualsteric/Bitopic Ligands
por: Gado, Francesca, et al.
Publicado: (2022)

Bitopic ligands: all-in-one orthosteric and allosteric
por: Kamal, Maud, et al.
Publicado: (2009)

Positive Allosteric Modulation of CB1 and CB2 Cannabinoid Receptors Enhances the Neuroprotective Activity of a Dual CB1R/CB2R Orthosteric Agonist
por: Polini, Beatrice, et al.
Publicado: (2020)

The Role of Cannabinoids in Bone Metabolism: A New Perspective for Bone Disorders
por: Saponaro, Federica, et al.
Publicado: (2021)

Synthesis and In Vitro Characterization of Selective Cannabinoid CB2 Receptor Agonists: Biological Evaluation against Neuroblastoma Cancer Cells
por: Gado, Francesca, et al.
Publicado: (2022)

Orthosteric and Allosteric Dual Targeting of the Nuclear Receptor RORγt with a Bitopic Ligand
por: Meijer, Femke A., et al.
Publicado: (2021)

The Role of Orthosteric Building Blocks of Bitopic Ligands for Muscarinic M1 Receptors
por: Volpato, Daniela, et al.
Publicado: (2020)

Discovery of Homobivalent Bitopic Ligands of the Cannabinoid CB(2) Receptor
por: Morales, Paula, et al.
Publicado: (2020)

Allosteric Modulation of the CB1 Cannabinoid Receptor by Cannabidiol—A Molecular Modeling Study of the N-Terminal Domain and the Allosteric-Orthosteric Coupling
por: Jakowiecki, Jakub, et al.
Publicado: (2021)

Traditional Uses of Cannabinoids and New Perspectives in the Treatment of Multiple Sclerosis
por: Gado, Francesca, et al.
Publicado: (2018)

Allosteric Antagonism of the A(2A) Adenosine Receptor by a Series of Bitopic Ligands
por: Gao, Zhan-Guo, et al.
Publicado: (2020)

Orthosteric and Allosteric Ligands of Nicotinic Acetylcholine Receptors for Smoking Cessation
por: Mohamed, Tasnim S., et al.
Publicado: (2015)

Structure of CC Chemokine Receptor 2 with Orthosteric and Allosteric Antagonists
por: Zheng, Yi, et al.
Publicado: (2016)

Analysis of equilibrium binding of an orthosteric tracer and two allosteric modulators
por: Jakubík, Jan, et al.
Publicado: (2019)

Orthosteric and allosteric modulation of human HCAR2 signaling complex
por: Mao, Chunyou, et al.
Publicado: (2023)

Dual Cannabinoid and Orexin Regulation of Anhedonic Behaviour Caused by Prolonged Restraint Stress
por: Kim, Hye Ji J., et al.
Publicado: (2023)

Differential regulation of muscarinic M(1 )receptors by orthosteric and allosteric ligands
por: Davis, Christopher N, et al.
Publicado: (2009)

Orthosteric and/or Allosteric Binding of α-Conotoxins to Nicotinic Acetylcholine Receptors and Their Models
por: Kryukova, Elena V., et al.
Publicado: (2018)

Cooperativity between the orthosteric and allosteric ligand binding sites of RORγt
por: de Vries, Rens M. J. M., et al.
Publicado: (2021)

On-target and off-target effects of novel orthosteric and allosteric activators of GPR84
por: Mancini, Sarah J., et al.
Publicado: (2019)

Orthosteric–allosteric dual inhibitors of PfHT1 as selective antimalarial agents
por: Huang, Jian, et al.
Publicado: (2021)

Anti-Proliferative Properties and Proapoptotic Function of New CB2 Selective Cannabinoid Receptor Agonist in Jurkat Leukemia Cells
por: Capozzi, Antonella, et al.
Publicado: (2018)

Design, Synthesis, and In Vitro Evaluation of Novel 8-Amino-Quinoline Combined with Natural Antioxidant Acids
por: Bacci, Andrea, et al.
Publicado: (2022)

Diphenyl-Methane Based Thyromimetic Inhibitors for Transthyretin Amyloidosis
por: Kim, Bokyung, et al.
Publicado: (2021)

Internalization of the chemokine receptor CCR4 can be evoked by orthosteric and allosteric receptor antagonists
por: Ajram, Laura, et al.
Publicado: (2014)

Protease-activated receptor-2 ligands reveal orthosteric and allosteric mechanisms of receptor inhibition
por: Kennedy, Amanda J., et al.
Publicado: (2020)

Molecular Modeling Study of a Receptor–Orthosteric Ligand–Allosteric Modulator Signaling Complex
por: Jiang, Chen, et al.
Publicado: (2023)

Orthosteric ligand selectivity and allosteric probe dependence at Hydroxycarboxylic acid receptor HCAR2
por: Cheng, Lin, et al.
Publicado: (2023)

FRET-Based Detection of M(1) Muscarinic Acetylcholine Receptor Activation by Orthosteric and Allosteric Agonists
por: Markovic, Danijela, et al.
Publicado: (2012)

Xanomeline displays concomitant orthosteric and allosteric binding modes at the M(4) mAChR
por: Burger, Wessel A. C., et al.
Publicado: (2023)

Contrasting Properties of α7-Selective Orthosteric and Allosteric Agonists Examined on Native Nicotinic Acetylcholine Receptors
por: Gill, JasKiran K., et al.
Publicado: (2013)

Activation of the Rat α1β2ε GABA(A) Receptor by Orthosteric and Allosteric Agonists
por: Germann, Allison L., et al.
Publicado: (2022)

5-HT(2C) Receptor Stimulation in Obesity Treatment: Orthosteric Agonists vs. Allosteric Modulators
por: Przegaliński, Edmund, et al.
Publicado: (2023)

Orthosteric- versus allosteric-dependent activation of the GABA(A) receptor requires numerically distinct subunit level rearrangements
por: Amin, Jahanshah, et al.
Publicado: (2017)

Allosterism vs. Orthosterism: Recent Findings and Future Perspectives on A(2B) AR Physio-Pathological Implications
por: Barresi, Elisabetta, et al.
Publicado: (2021)

The Binding Mode to Orthosteric Sites and/or Exosites Underlies the Therapeutic Potential of Drugs Targeting Cannabinoid CB(2) Receptors
por: Franco, Rafael, et al.
Publicado: (2022)

Novel Electrophilic and Photoaffinity Covalent Probes for Mapping the Cannabinoid 1 Receptor Allosteric Site(s)
por: Kulkarni, Pushkar M., et al.
Publicado: (2015)

Indomethacin Enhances Type 1 Cannabinoid Receptor Signaling
por: Laprairie, Robert B., et al.
Publicado: (2019)

Predicting Allosteric Effects from Orthosteric Binding in Hsp90-Ligand Interactions: Implications for Fragment-Based Drug Design
por: Chandramohan, Arun, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gteihdceck5f76kh47c7hjv4am